Cancer Research News
UF Health study provides guidance to avoid unnecessary thyroid biopsies
The number of people diagnosed with thyroid cancer has more than quadrupled in the last 40 years, even as the disease’s death rate remained relatively unchanged.
It is a classic case of disease overdiagnosis, with little resulting benefit for many patients, said University of Florida Health endocrinologist Naykky Singh Ospina, M.D., an assistant professor in the UF College of Medicine’s division of endocrinology, diabetes and metabolism and a member of the UF Health Cancer Center. READ MORE
Coronavirus 2019: What People With Cancer Need to Know
By Merry Jennifer Markham, M.D., FACP, interim chief of the UF Division of Hematology & Oncology, an associate professor in the UF department of medicine, and the associate director for medical affairs at the UF Health Cancer Center
Coronavirus disease 2019 (or COVID-19) is a respiratory illness caused by a novel (or new) coronavirus that was first identified in an outbreak in Wuhan, China, in December 2019.
Coronaviruses are a large family of viruses that can cause mild illnesses, such as the common cold, to more severe diseases, such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Because the novel coronavirus is related to the SARS-associated coronavirus (SARS-CoV), it has been named SARS-CoV-2. READ MORE
Dr. Gibbs on the lack of treatment options in sarcoma
C. Parker Gibbs Jr, M.D., Eugene L. Jewett professor of orthopaedic surgery, chief medical officer at the University of Florida Health Shands Hospital and division chief of orthopaedic oncology in the University of Florida College of Medicine, discusses the lack of treatment options for patients with soft tissue and bone sarcomas. READ MORE
Gastrointestinal Patient-Reported Outcomes
Anamaria R. Yeung, M.D., is the corresponding author for the Journal of Clinical Oncology article.
In an analysis from the NRG Oncology RTOG 1203 study reported in the Journal of Clinical Oncology, Yeung et al found improved patient-reported gastrointestinal toxicity with intensity-modulated radiotherapy vs standard radiotherapy among patients with cervical or endometrial cancer requiring postoperative radiotherapy. The analysis also showed that clinicians underreported gastrointestinal adverse events compared with patients. READ MORE
NSABP B-42 Trial 10-Year Update: Impact of Extended Letrozole on Disease-Free Survival
“In the 10-year analysis of the NSABP B-42 trial, the effect of extended treatment with 5 years of letrozole on disease-free survival persisted and reached statistical significance. There was no significant improvement in overall survival with letrozole, but letrozole continued to provide a significant improvement in breast cancer–free interval and distant recurrence,” said Terry P. Mamounas, M.D., M.P.H., medical director of the Comprehensive Breast Program at Orlando Health University of Florida Health Cancer Center, and chair of the NRG Oncology Breast Committee. READ MORE
COVID-19: Older Patients With Cancer Especially Vulnerable
“Oncology clinicians are well versed in caring for immunosuppressed patients with cancer, of all ages,” Merry Jennifer Markham, M.D., FACP, interim chief of the Division of Hematology & Oncology at the University of Florida in Gainesville, told Medscape Medical News. READ MORE